Annual CFO
-$2.56 M
-$1.54 M-151.88%
31 December 2023
Summary:
CytoMed Therapeutics Limited annual cash flow from operations is currently -$2.56 million, with the most recent change of -$1.54 million (-151.88%) on 31 December 2023. During the last 3 years, it has fallen by -$1.94 million (-314.84%). GDTC annual CFO is now -314.84% below its all-time high of -$616.10 thousand, reached on 01 December 2020.GDTC Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
GDTC Cash From Operations Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | -151.9% | - | - |
3 y3 years | -314.8% | - | - |
5 y5 years | - | - | - |
GDTC Cash From Operations High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3 years | -314.8% | at low | ||||
5 y | 5 years | -314.8% | at low | ||||
alltime | all time | -314.8% | at low |
CytoMed Therapeutics Limited Cash From Operations History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Dec 2023 | -$2.56 M(+151.9%) | - | - |
Dec 2022 | -$1.01 M(-20.4%) | - | - |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Dec 2021 | -$1.27 M(+106.9%) | - | - |
Dec 2020 | -$616.10 K | - | - |
FAQ
- What is CytoMed Therapeutics Limited annual cash flow from operations?
- What is the all time high annual CFO for CytoMed Therapeutics Limited?
- What is CytoMed Therapeutics Limited annual CFO year-on-year change?
What is CytoMed Therapeutics Limited annual cash flow from operations?
The current annual CFO of GDTC is -$2.56 M
What is the all time high annual CFO for CytoMed Therapeutics Limited?
CytoMed Therapeutics Limited all-time high annual cash flow from operations is -$616.10 K
What is CytoMed Therapeutics Limited annual CFO year-on-year change?
Over the past year, GDTC annual cash flow from operations has changed by -$1.54 M (-151.88%)